Home

excel proizvesti Olakšajte re dual pci trial ppt Prošao naučite Poslaniče

Presentation slide: RE-DUAL PCI –antithrombotic therapy in AF patients who  have undergone stent PCI | boehringerone.com
Presentation slide: RE-DUAL PCI –antithrombotic therapy in AF patients who have undergone stent PCI | boehringerone.com

Ticagrelor versus clopidogrel in elective percutaneous coronary  intervention (ALPHEUS): a randomised, open-label, phase 3b trial - The  Lancet
Ticagrelor versus clopidogrel in elective percutaneous coronary intervention (ALPHEUS): a randomised, open-label, phase 3b trial - The Lancet

Edoxaban-based versus vitamin K antagonist-based antithrombotic regimen  after successful coronary stenting in patients with atrial fibrillation  (ENTRUST-AF PCI): a randomised, open-label, phase 3b trial - The Lancet
Edoxaban-based versus vitamin K antagonist-based antithrombotic regimen after successful coronary stenting in patients with atrial fibrillation (ENTRUST-AF PCI): a randomised, open-label, phase 3b trial - The Lancet

Risk of Stroke vs. Intracerebral Hemorrhage in Patients with Non-Valvular  Atrial Fibrillation Undergoing Percutaneous Coronary Intervention: A  Systematic Review and Meta-Analysis of Randomized Controlled Trials  Comparing Dual vs. Triple Antithrombotic ...
Risk of Stroke vs. Intracerebral Hemorrhage in Patients with Non-Valvular Atrial Fibrillation Undergoing Percutaneous Coronary Intervention: A Systematic Review and Meta-Analysis of Randomized Controlled Trials Comparing Dual vs. Triple Antithrombotic ...

TWILIGHT: A Randomized Trial of Ticagrelor Monotherapy Versus Ticagrelor  Plus Aspirin Beginning at 3 Months in High-risk Patients Undergoing  Percutaneous Coronary Intervention | USC Journal
TWILIGHT: A Randomized Trial of Ticagrelor Monotherapy Versus Ticagrelor Plus Aspirin Beginning at 3 Months in High-risk Patients Undergoing Percutaneous Coronary Intervention | USC Journal

The RE-DUAL PCI Trial: Dabigatran in Patients With ACS and Atrial  Fibrillation: Design, Rationale, and Status | tctmd.com
The RE-DUAL PCI Trial: Dabigatran in Patients With ACS and Atrial Fibrillation: Design, Rationale, and Status | tctmd.com

on behalf of the RE-DUAL PCI Steering Committee and Investigators - ppt  download
on behalf of the RE-DUAL PCI Steering Committee and Investigators - ppt download

Antithrombotic therapy in atrial fibrillation patients with coronary artery  disease: shifting paradigm to a “less is more” concept regimen - Journal of  Cardiology
Antithrombotic therapy in atrial fibrillation patients with coronary artery disease: shifting paradigm to a “less is more” concept regimen - Journal of Cardiology

on behalf of the RE-DUAL PCI Steering Committee and Investigators - ppt  download
on behalf of the RE-DUAL PCI Steering Committee and Investigators - ppt download

The Challenge of AF and PCI: Practical Strategies to Improve Outcomes - ppt  download
The Challenge of AF and PCI: Practical Strategies to Improve Outcomes - ppt download

Superior safety of dual therapy with dabigatran and clopidogrel vs. triple  therapy with warfarin, aspirin and clopidogrel in the RE-DUAL PCI trial:  What is key, the strategy or the drug? - European
Superior safety of dual therapy with dabigatran and clopidogrel vs. triple therapy with warfarin, aspirin and clopidogrel in the RE-DUAL PCI trial: What is key, the strategy or the drug? - European

Dual Antithrombotic Therapy with Dabigatran after PCI in Atrial  Fibrillation | NEJM
Dual Antithrombotic Therapy with Dabigatran after PCI in Atrial Fibrillation | NEJM

Triple therapy: A review of antithrombotic treatment for patients with  atrial fibrillation undergoing percutaneous coronary intervention - Journal  of Cardiology
Triple therapy: A review of antithrombotic treatment for patients with atrial fibrillation undergoing percutaneous coronary intervention - Journal of Cardiology

Dual Antithrombotic Therapy with Dabigatran after PCI in Atrial  Fibrillation | NEJM
Dual Antithrombotic Therapy with Dabigatran after PCI in Atrial Fibrillation | NEJM

Triple Antithrombotic Therapy in AF Patients Undergoing PCI - Dr. Mar…
Triple Antithrombotic Therapy in AF Patients Undergoing PCI - Dr. Mar…

Contemporary Revascularization Dilemmas in Older Adults | Journal of the  American Heart Association
Contemporary Revascularization Dilemmas in Older Adults | Journal of the American Heart Association

Ticagrelor With or Without Aspirin After Complex PCI | Journal of the  American College of Cardiology
Ticagrelor With or Without Aspirin After Complex PCI | Journal of the American College of Cardiology

Evaluation of the safety and efficacy of an edoxaban-based antithrombotic  regimen in patients with atrial fibrillation following successful  percutaneous coronary intervention (PCI) with stent placement: Rationale  and design of the ENTRUST-AF PCI
Evaluation of the safety and efficacy of an edoxaban-based antithrombotic regimen in patients with atrial fibrillation following successful percutaneous coronary intervention (PCI) with stent placement: Rationale and design of the ENTRUST-AF PCI

Triple therapy: A review of antithrombotic treatment for patients with  atrial fibrillation undergoing percutaneous coronary intervention - Journal  of Cardiology
Triple therapy: A review of antithrombotic treatment for patients with atrial fibrillation undergoing percutaneous coronary intervention - Journal of Cardiology

on behalf of the RE-DUAL PCI Steering Committee and Investigators - ppt  download
on behalf of the RE-DUAL PCI Steering Committee and Investigators - ppt download

Triple Antithrombotic Therapy in AF Patients Undergoing PCI - Dr. Mar…
Triple Antithrombotic Therapy in AF Patients Undergoing PCI - Dr. Mar…

2018 Canadian Cardiovascular Society/Canadian Association of Interventional  Cardiology Focused Update of the Guidelines for the Use of Antiplatelet  Therapy - Canadian Journal of Cardiology
2018 Canadian Cardiovascular Society/Canadian Association of Interventional Cardiology Focused Update of the Guidelines for the Use of Antiplatelet Therapy - Canadian Journal of Cardiology

Comparison of the Effect of Age (< 75 Versus ≥ 75) on the Efficacy and  Safety of Dual Therapy (Dabigatran + Clopidogrel or Ticagrelor) Versus  Triple Therapy (Warfarin + Aspirin + Clopidogrel
Comparison of the Effect of Age (< 75 Versus ≥ 75) on the Efficacy and Safety of Dual Therapy (Dabigatran + Clopidogrel or Ticagrelor) Versus Triple Therapy (Warfarin + Aspirin + Clopidogrel

Atrial Fibrillation and PCI - ppt download
Atrial Fibrillation and PCI - ppt download

Comparison of Dabigatran Plus a P2Y12 Inhibitor With Warfarin-Based Triple  Therapy Across Body Mass Index in RE-DUAL PCI - The American Journal of  Medicine
Comparison of Dabigatran Plus a P2Y12 Inhibitor With Warfarin-Based Triple Therapy Across Body Mass Index in RE-DUAL PCI - The American Journal of Medicine

Evaluation of Dual Versus Triple Therapy by Landmark Analysis in the RE-DUAL  PCI Trial | JACC: Cardiovascular Interventions
Evaluation of Dual Versus Triple Therapy by Landmark Analysis in the RE-DUAL PCI Trial | JACC: Cardiovascular Interventions